In case it was missed !!! From Marc Sinatra (lodge partners) on Twitter: "Just released a report on Factor Therapeutics $FTT. Looks highly undervalued. NPV = 33.5 cents/share (fully diluted) prior to phase IIb readout in Q4 CY18. NPV = 52 cents after, if +ve. Multiple catalysts to get it there. It’s a good one! @biotech_daily @asxlongtail @Factor_Tx"